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Curcumin, the primary bioactive substance in turmeric, is known to be associated with weight loss. In this study,
we employed Caenorhabditis elegans, a well-established in vivo nematode model to explore the role of curcumin in
regulating lipid metabolism. C. elegans administrated with curcumin (10, 25 and 50 μM) exhibited significantly
reduced fat accumulation, along with smaller body size (width) when compared to the control, without signif
icantly affecting the feeding behavior. Locomotive activity (average moving speed) was significantly increased
by curcumin treatment, suggesting a potential increase in energy expenditure. The reduced fat accumulation by
curcumin was dependent on lipogenesis-associated genes, sbp-1 (encodes the homolog of sterol response element
binding proteins) and fat-6 (encodes a homolog of stearoyl-CoA desaturase), as curcumin significantly downregulated the expression levels of these two genes and its fat reduction effect was nulled by the mutation of
sbp-1 and fat-6. Additionally, the increased locomotive activity by curcumin was dependent on sbp-1. Current
results suggest that curcumin decreases fat accumulation by inhibiting sbp-1/fat-6-mediated signaling in Cae
norhabditis elegans.

1. Introduction
In recent decades, incidence of obesity is increasing at an alarming
rate worldwide and continues to be a major global public health
concern. In the United States, the prevalence of obesity increased from
30.5% to 42.4%, and the prevalence of severe obesity increased from
4.7% to 9.2% from 1999 to 2018 (Centers for Disease Control and Pre
vention, 2020). Therefore, increasing attention has been given to
research on ways to slow the development of obesity, such as identifi
cation of food/plant-based compounds that can effectively regulate
energy and lipid metabolism. Among them, curcumin, a diarylheptanoid
present in Curcuma longa plants, has received considerable research in
terest in its biological properties (Aggarwal et al., 2003; Menon and
Sudheer 2007; Negi et al., 1999; Lee et al., 2010). This includes curcu
min’s anti-obesity effect, such as inhibiting adipogenesis in 3T3-L1 ad
ipocytes and attenuating high fat diet-induced obesity and insulin
resistance in rodent models (Shehzad et al., 2011; Budiman et al., 2015).
Caenorhabditis elegans, a free-living, multi-organ, microscopic and
transparent round worm, has been widely utilized in many research
fields, including the study of obesity (Shen et al. 2017b, 2018b). It has a
compact body size (~1 mm adulthood), short lifecycle (~21 days), large
brood size (~300 embryos by self-fertilization), fully-sequenced

genome, and a large availability of transgenic and mutant strains.
Moreover, core lipid metabolic pathways, including lipogenesis,
β-oxidation, and energy homeostasis, are conserved in C. elegans (Shen
et al. 2017b, 2018b). Previously, curcumin has been reported to extend
the lifespan and enhance stress responses in C. elegans; however, there is
no research on the effects of curcumin on lipid metabolism in this model.
Thus, in the current research, we investigated the role of curcumin in
lipid metabolism in C. elegans.
2. Materials and methods
2.1. Materials
Curcumin (C1386, CAS-No. 458-37-7) was purchased from SigmaAldrich Co. (St. Louis, MO). Biological agar and other chemicals for
C. elegans maintenance were all purchased from Thermo Fisher Scientific
Inc. (Middletown, VA), unless otherwise stated. Ampicillin and carbe
nicillin were purchased from Sigma-Aldrich Co. (St. Louis, MO).
Household bleach (The Clorox company, Oakland, CA) was obtained in a
local supermarket. Reagents for triglyceride (Triglyceride, Infinity™
Triglyceride Reagent) and protein (Bio-Rad DC protein assay kit) mea
surement were purchased from Thermo Fisher Scientific Inc.
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(Middletown, VA) and Bio-Rad Co. (Hercules, CA), respectively. The
high-capacity cDNA reverse transcription kit, TaqMan™ gene expres
sion assays, and Master Mix were purchased from Thermo Fisher Sci
entific, Inc. (Middletown, VA). Bacterial strain Escherichia coli OP50 and
C. elegans strains N2 Bristol (wild type), sbp-1 (ep79) III, nhr-49 (ok2165)
I, fat-5 (tm420) V, fat-6 (tm331) IV, fat-7 (wa36) V, aak-2 (ok524) X were
obtained from the Caenorhabditis Genetics Center (CGC).

temperature at 50 ◦ C, increased to 200 by 20 ◦ C/min, held for 30 min
then increase to 220 ◦ C by 2 ◦ C/min and hold for 162.5 min. MS
interface was 220 ◦ C and ion source was 200 ◦ C. An electron ionization
(EI) with 70 eV with full scan mode in 35–500 m/z range with 0.3× of
scan time were used. Fatty acid methyl esters were identified by
comparing with standards and/or their mass spectra of the National
Institute of Standards and Technology (NIST) Mass Spectral Library as
previously described (Yue et al., 2019). The desaturation index was
calculated as % of oleic acid over % of stearic acid (Yue et al., 2019).

2.2. C. elegans culture
C. elegans strains were maintained as previously described (Yue et al.,
2019) in nematode growth medium (NGM) with freshly prepared
Escherichia coli OP50 as the food source. The synchronized population
was prepared by the standard bleaching method (Yue et al., 2019).
Treatments were administrated in a liquid S-complete medium, along
with ampicillin (100 μg/mL), carbenicillin (50 μg/mL), E. coli OP50 (8
mg wet weight/mL) and curcumin in dimethyl sulfoxide (DMSO) with a
final concentration of 0.1% DMSO. Based on the previous publication of
curcumin in C. elegans where up to 200 μM curcumin improved survival
after oxidative stress (Yu et al., 2014), dosages of 10, 25 and 50 μM were
chosen in the current study. For all experiments treatments were started
from the 1st day of adulthood for 2 days at 20 ◦ C.

2.7. Statistical analyses
Data were presented as mean ± S.E. Using SAS Software (version 9.4,
SAS Institute, Cary, NC), results were analyzed by one-way analysis of
variance (ANOVA), followed by the Tukey’s multiple comparison test
for the comparisons among groups. P < 0.05 was considered statistically
significant.
3. Results
3.1. Curcumin reduced fat accumulation of C. elegans
As shown in Fig. 1, curcumin at concentrations of 10 μM (P =
0.0020), 25 μM (P < 0.0001), and 50 μM (P < 0.0001) significantly
reduced fat accumulation in C. elegans by 7–15% when compared to the
control group, while no significance was observed in the 5 μM curcumintreated group. This suggests that curcumin dose-dependently reduced
fat accumulation at concentrations equal to and higher than 10 μM in
C. elegans.

2.3. Triglyceride and protein measurement
Triglyceride and protein measurements were performed as previ
ously reported (Yue et al., 2019). After treatment, worms were collected
and washed thrice with sterilized water. Samples were prepared by
sonication in 0.05% Tween 20 for 3 min. Triglyceride and protein were
measured using the Infinity™ Triglyceride Reagent and Bio-Rad DC
protein assay kit, respectively, according to the manufacturer’s in
structions. Protein content was used as the internal control to normalize
the triglyceride level.

3.2. Effect of curcumin on food intake, body size, and locomotive activity
Next, we examined the effect of curcumin on several physiological
parameters: food intake, body size, and locomotive activity. Curcumin at
both 10 and 25 μM did not influence the pharyngeal pumping rate, a
food intake indicator, suggesting that the feeding behavior was not
influenced by curcumin (Fig. 2A). Locomotive activity was measured as
the average moving speed, which was significantly increased by cur
cumin at 10 (29% increase, P = 0.0073) and 25 μM (32% increase, P =
0.0031) compared to the control (Fig. 2B). This suggests that the
increased energy expenditure caused by curcumin might be a potential
contributor to the observed fat-lowering effect of curcumin (Shen et al.,
2018a). Moreover, nematodes from curcumin groups showed

2.4. Pharyngeal pumping rate, worm size and locomotive activity
The pharyngeal pumping rate was recorded as previously reported
(Yue et al., 2019). After treatment, 12 worms per treatment were
randomly selected and the pumping rate was monitored by counting the
pharyngeal contraction under an optical microscope for 30s. Body size
(length and width) and average moving speed were determined by the
WormLab Tracking system (MBF Bioscience, Williston, VT) as previ
ously described (Yue et al., 2019). Pre-treated worms were transferred to
a low peptone NGM plate seeded with a thin layer of freshly prepared
E. coli OP50. After 10 min of acclimation, a 1 min video was recorded
and analyzed with the WormLab software (MBF Bioscience version 3. 1.
0, Williston, VT) for body size and average moving speed.
2.5. Reverse transcription quantitative real-time PCR
Real-time PCR was performed as previously described (Yue et al.,
2019). Total RNA was extracted by Trizol. A high-capacity cDNA reverse
transcription kit was used to generate cDNA. Real-time PCR was per
formed using the StepOnePlus™ Real-Time PCR system (Applied Bio
systems, Foster City, CA). TaqMan™ gene expression assays used were
sbp-1 (Ce02453000_m1), fat-6 (Ce02465318_g1) and ama-1
(Ce02462726_m1, an internal control).
2.6. Fatty acid composition analysis
Total fat were extracted and methylated as previously described
(Colmenares et al., 2016). Fatty acid methyl esters were then injected for
GC/MS analysis (Shimadzu GCMS-QP2010 SE, Tokyo, Japan) using
Supelcowax-10 fused silica column (100 m × 0.25 mm i.d., 0.25 μm film
thickness, Sigma-Aldrich, St. Louis, MO) with helium as the carrier gas.
Temperature of injector was 250 ◦ C. Running condition was initial

Fig. 1. Curcumin decreased triglyceride accumulation in wild-type N2
C. elegans. Synchronized 1st day adult worms were cultured and treated with
control (0.1% DMSO) or curcumin (5, 10, 25 and 50 μM in DMSO) for 2 days at
20 ◦ C. Triglyceride content was measured and normalized by protein levels.
Results are expressed as mean ± S.E. (n = 3–4 plates, each plate >1000 worms).
Means with different letters are significantly different at P < 0.05.
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Fig. 2. Effect of curcumin on normal physiological
parameters in C. elegans. Synchronized 1st day adult
worms were treated with control (0.1% DMSO) or
curcumin (10 and 25 μM in DMSO) for 2 days at
20 ◦ C. (A) Pumping rate was monitored by counting
the pharyngeal contractions per 30s. Results are
expressed as mean ± S.E. (n = 12). For body size
and locomovitve activity, pre-treated worms were
transferred to a freshly-prepared, E. coli OP50seeded low-peptone plate, and normal physioco
logical parameters, including average moving speed
(B), width (C), and length (D), were measured and
analyzed using the WormLab software. Results are
expressed as mean ± S.E. (n = 52–69). Means with
different letters are significantly different at P <
0.05.

fat reduction in both mammals (Dobrzyn and Ntambi 2005; Cohen et al.,
2003) and C. elegans (Shen et al., 2018b). In C. elegans, SCDs are encoded
by fat-5, fat-6, and fat-7. Therefore, we examined the effect of curcumin
on the sbp-1, fat-5, fat-6, and fat-7 mutant strains. As shown in Fig. 3A,
the fat lowering effect of curcumin was successfully abolished in the
sbp-1 and fat-6, but not fat-5 and fat-7 mutants, indicating the genetic
requirement of sbp-1 and fat-6 for curcumin’s fat reduction effect. To
further delineate the role of curcumin on sbp-1 and fat-6, we next per
formed real-time PCR on these two genes in wild-type nematodes. As
shown in Fig. 3B, the mRNA expression levels of sbp-1 and fat-6 were
significantly down-regulated by curcumin treatment, suggesting that
curcumin inhibits sbp-1 and its target fat-6 to reduce fat accumulation in
C. elegans.
nhr-49, a gene that encodes a functional homolog of peroxisome
proliferator-activated receptors (PPARs) in C. elegans (Shen et al.,
2018b; Van Gilst et al., 2005), is another upstream regulator of SCDs,
and also plays an essential role in regulating fatty acid β-oxidation (Shen
et al., 2018b; Van Gilst et al., 2005). However, a mutation of nhr-49
failed to abolish the effect of curcumin on fat reduction (Fig. 3A), sug
gesting that nhr-49 is not necessarily a contributor to curcumin’s effect
on SCDs and fat accumulation.

significantly decreased worm width (Fig. 2C) at 10 μM (12% decrease, P
= 0.0034) and 25 μM (10% decrease, P = 0.0352) compared to the
control, while no significance was observed on worm length (Fig. 2D).
The reduced body size is likely due to the reduced overall fat accumu
lation by curcumin. Taken together, these results suggest that curcumin,
at 10 or 25 μM, reduced the body size and increased locomotive activity
without changing the food intake in C. elegans.
3.3. Curcumin reduced fat accumulation via sbp-1 and fat-6
To explore the underlying molecular target(s) of curcumin’s fat
reduction, real-time PCR and gene knock-out mutant strains were
employed to identify the role of curcumin in lipid metabolism. SBP-1,
the single homolog of sterol response element binding proteins
(SREBPs), plays a crucial role in regulating lipogenesis (Shen et al.,
2018b; Xiao and Song 2013). It acts as the upstream regulator of
stearoyl-CoA desaturase (SCDs) that are responsible for catalyzing the
rate-limiting step in the formation of monounsaturated fatty acids from
saturated fatty acids (Shen et al., 2018b). It has been suggested that
SCDs are potential drug targets for obesity treatment (Cohen et al., 2003;
Dobrzyn and Ntambi 2005) as deficiency in SCDs has resulted in overall

Fig. 3. Effect of curcumin on lipid metabolism in
C. elegans. (A) Effect of curcumin on different
mutant strains. Synchronized 1st day adult
worms were treated with control (0.1% DMSO,
white bars) or curcumin (10 μM in DMSO, gray
bars) for 2 days at 20 ◦ C, then harvested for tri
glycerides analysis. Triglycerides content was
normalized by protein level. (B) Effect of curcu
min on the mRNA expressions of sbp-1 and fat-6.
Results are expressed as mean ± S.E. (n = 3
plates, each plate >1000 worms for A and >8000
worms for B). Means with different letters are
significantly different at P < 0.05. Tested genes
are sbp-1 (sterol regulatory element binding
protein-1), nhr-49 (nuclear hormone receptor49), fat-5 (fatty acid desaturase-5), fat-6 (fatty
acid desaturase-6), fat-7 (fatty acid desaturase-7),
and aak-2 (AMP-activated kinase-2).
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aak-2 encodes one of the subunits that was suggested to be respon
sible for the kinase activity of AMP-activated protein kinase (AMPK), an
energy sensor that regulates metabolic energy balance at the wholebody level (Hardie et al., 2012). As observed in wild type N2 worms,
curcumin significantly reduced fat accumulation in aak-2 mutant nem
atodes (Fig. 3A), suggesting that aak-2 may not be an essential genetic
requirement for curcumin’s fat reduction effect. Collectively, these re
sults suggest that curcumin reduced fat accumulation via sbp-1/fat-6-
mediated signaling.
3.4. Curcumin significantly reduced fatty acid desaturation index
To further determine the roles of sbp-1/fat-6 in curcumin’s fat
reduction effect, fatty acid composition of C. elegans was analyzed. As
shown in Fig. 4, the desaturation index, the conversion rate of stearic
acid to oleic acid, was significant reduced by curcumin treatment at 25
μM by 34% when compared to the control group (P = 0.0124), while no
significant effect was observed at 10 μM curcumin treatment.
3.5. Curcumin altered locomotive activity via sbp-1
Since treatment of curcumin significantly increased the locomotive
activity in wild-type nematodes, we determined next if this effect of
curcumin is also mediated by sbp-1 and fat-6 using mutant strains.
Additionally, since it is known that AMPK activation is positively related
to locomotive activity in C. elegans (Shen et al., 2018a), the effect of
curcumin in the aak-2 mutant was also examined to determine if cur
cumin increased locomotive activity via aak-2.
No significant change was observed in the average moving speed
between the control and curcumin-treated sbp-1 mutants (Fig. 5A),
which indicates that curcumin’s effect on locomotive activity was fully
abolished by the sbp-1 mutation. However, curcumin treatment signifi
cantly increased the average moving speed in the fat-6 and aak-2 mu
tants, dose-dependently (Fig. 5B and C); fat-6 mutants exhibited 29% (P
< 0.0001) and 69% (P = 0.0028) increases, and aak-2 worms showed
21% (P = 0.0419) and 27% (P = 0.0041) increases at 10 and 25 μM,
respectively, compared to the control groups. These observations sug
gest that these two genes, fat-6 and aak-2, are not the genetic require
ment for curcumin’s effect on locomotive activity. Taken together, the
results above suggest that the increased locomotive activity by curcumin
was dependent on sbp-1.

Fig. 5. Effect of curcumin on locomotive activity. Synchronized 1st day adult
sbp-1, fat-6, and aak-2 mutant worms were treated with control (0.1% DMSO)
or curcumin (10 and 25 μM in DMSO) for 2 days at 20 ◦ C. After treament,
worms were transferred to a fresh E. coli OP50-seeded low-peptone plate,
locomotive activity of sbp-1 (A), fat-6 (B) and aak-2 (C) mutant worms were
monitored and analyzed by the WormLab Tracking System. Results are
expressed as mean ± S.E. (n = 29–30 for sbp-1; n = 26–29 for fat-6; and n =
25–30 for aak-2). Means with different letters are significantly different at P
< 0.05.

4. Discussion
In the present study, curcumin at concentrations ≥10 μM signifi
cantly reduced fat accumulation in C. elegans without affecting the
feeding behavior. Worm width was significantly reduced under curcu
min treatment, likely due to the reduced fat content, as seen in previous
publications (Farias-Pereira et al., 2018; Shen et al., 2017a). These ef
fects of curcumin were dependent upon sbp-1 and its target fat-6, as seen

Fig. 4. Effect of curcumin on the desaturation index. Synchronized 1st day
adult worms were treated with control (0.1% DMSO) or curcumin (10 and 25
μM in DMSO) for 2 days at 20 ◦ C. After treatment, fatty acid composition of
worms were analyzed by GC/MS and the desaturation index were calculated as
% of oleic acid/% of stearic acid. Results are expressed as mean ± S.E. (n = 3
plates, each plate >6000 worms). Means with different letters are significantly
different at P < 0.05.
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in reduced gene expression and fully abolished effects on fat accumu
lation in sbp-1 and fat-6 mutant strains. In addition to elucidate the sbp-1
dependent fat-reduction mechanisms of curcumin, current study was
also the first study that identified the role of sbp-1 by curcumin in
regulating locomotive activity.
SBP-1, a homolog of SREBP transcription factor, is a crucial regulator
that facilitates fat storage in C. elegans. Knockdown of sbp-1 caused a
reduction in overall body fat storage, body size, and brood size, and it
altered the expression of lipogenesis-related genes such as SCDs (Yue
et al., 2019; Shen et al., 2018b). Our results showed that curcumin de
creases fat accumulation via SBP-1/SCDs-mediated signaling, which is
consistent with a previous report in rodent models (Ding et al., 2016).
Similar to curcumin, other functional food ingredients, such as picea
tannol (Shen et al., 2017a), cranberry extract (Sun et al., 2016), green
coffee extract, 5-O-caffeoylquinic acid (Farias-Pereira et al., 2018), and
hesperidin (Peng et al., 2016) were also reported to regulate lipid
metabolism via sbp-1-mediated mechanisms, indicating that sbp-1 may
be a useful therapeutic target of bioactive components for obesity pre
vention and treatment.
The current results show that 25 μM curcumin significantly reduced
the desaturation index over the control, which is consistent to reduced
fat-6 expression by curcumin treatment (Fig. 3B). However, curcumin
treatment at 10 μM did not significantly reduce the desaturation index
over the control. As the downstream targets of sbp-1, both fat-6 and fat-7
encode delta 9 desaturase with more than 80% genetic homology (Van
Gilst et al., 2005) and the compensatory mechanism of each other has
been reported (Brock et al., 2006). Thus, it is possible that effects of
curcumin at 10 μM were overcome by the compensatory mechanism of
fat-7, while this may not be enough at 25 μM curcumin treatment.
However, butein, a flavonoid found in annatto seeds and lacquer trees,
reduces fat accumulation dependent on fat-7, but not fat-6, without
significant changes on the desaturation index (Farias-Pereira et al.,
2020). The different results of the desaturation index between the cur
rent and Farias-Pereira et al. (2020) may be explained that fat-6 occurs
to be a more essential contributor for this desaturation process, as fat-6
mutant desplays signficant changes of increased stearic acid and
decreased oleic acid, while no significant differences in desaturation
were observed in fat-7 mutant (Brock et al., 2006).
Locomotive activity is known to be regulated by the nervous system
(Gjorgjieva et al., 2014; Kiehn and Dougherty), and curcumin has been
reported to improve locomotive activity in various disease models of
neuropathies via its neuroprotective effects, as well as its ability to
stimulate axonal regrowth in rodents (Caillaud et al., 2020). Consis
tently, in the current study we observed that curcumin significantly
increased the locomotive activity of C. elegans, dependent on sbp-1. The
mechanisms for how sbp-1 modulates locomotive activity are unclear;
however, considering that sbp-1 is expressed in both intestinal and
amphid neurons (Wormbase), it is possible that neuronal sbp-1 may play
a role in this modulation, and hence may alter the locomotion of
C. elegans. The exact mechanisms for how sbp-1 contributes to the
alteration of locomotive activity by curcumin and the role of how sbp-1
regulate fat accumulation and locomotion needs further study.
Curcumin was previously reported to be an AMPK agonist (Liu et al.,
2017), and AMPK activation was found to be associated with increased
locomotive activity in C. elegans (Shen et al., 2018a). However, the
current results show that aak-2 appears to be an insignificant contributor
to curcumin’s effects on fat accumulation and locomotive activity in
C. elegans, as aak-2 mutation failed to abolish curcumin’s effects for both
parameters. In addition to aak-2, C. elegans has another gene, aak-1, that
also encodes one of the catalytic alpha subunits of mammalian AMPK
(Shen et al., 2018b). Thus, we cannot exclude the possibility that aak-1
plays a role in the observed effects of curcumin in the current study.
The relation between curcumin and PPARs is a matter of much
current debate. Some publications suggest curcumin acts as a PPARγ and
PPARα/γ ligand (Jacob et al., 2008; Mazidi et al., 2016; Pan et al.,
2017), while others indicate curcumin is not a PPARγ agonist (Narala

et al., 2009). Our current results showed that nhr-49, a functional ho
molog for PPARs, failed to abolish curcumin’s effect on fat accumula
tion, which suggests that curcumin does not act via PPARs for its
fat-lowering effect in this model.
Though curcumin is well known to have a broad spectrum of health
benefits, its poor pharmacokinetic profile compromises its therapeutic
potential (Dei Cas and Ghidoni 2019). After oral uptake, curcumin un
dergoes efficient first-pass metabolism and some degree of the intestinal
metabolism, particularly glucuronidation and sulfation, yet has low
systemic absorption and availability (Dei Cas and Ghidoni 2019; Sharma
et al., 2007). Strategies for improving curcumin’s bioavailability have
been extensively studied. These include inhibition of curcumin meta
bolism with adjuvants as well as the development of innovative solid
and liquid oral delivery systems to enhance solubility and improve the
pharmacokinetic profile of curcumin (Dei Cas and Ghidoni 2019).
However, others suggest taking a cautious approach in consideration of
potential adverse effects associated with the increased bioavailability of
curcumin (Burgos-Morón et al., 2010). Still, an increasing number of
studies have begun to report evidence for therapeutic benefits attributed
to curcumin metabolites (Gutierres et al., 2015; Edwards et al., 2017).
As C. elegans also conserves xenobiotic metabolism pathways (Lindblom
and Dodd 2006; Harlow et al., 2018), it is possible that curcumin me
tabolites may play a role in the observed effects of the current study.
According to the Joint United Nations and World Health Organiza
tion Expert Committee on Food Additives, the allowable daily intake
(ADI) of curcumin is 0–3 mg/kg body weight, based on a NOEL of
250–320 mg/kg body weight/day in a multigeneration study in rats with
a safety factor of 100 (WHO). Human clinical studies of curcumin
employed a wide range of dosages from 0.1 to 12 g/day, and some of
them have shown promising results for the application of curcumin to
the alleviation of markers of various pathologies, such as inflammation,
oxidative stress, and liver function, without showing significant
side-effects (Mousavi et al., 2020; Saraf-Bank et al., 2019; Ganjali et al.,
2014; Panahi et al., 2016; Dei Cas and Ghidoni 2019; Mohammadi et al.,
2018). Based on the current results, curcumin at concentrations equal
and higher than 10 μM effectively reduced fat accumulation in
C. elegans. However, given the limitations of the C. elegans model (lack of
certain organs and a circulatory system), a direct translation of dosages
from C. elegans to humans is not currently possible (Shen et al. 2017b,
2018b). Effective dosages need to be carefully examined while inter
preting current results in other models or human clinical trials.
In conclusion, the current study suggests that curcumin reduces fat
accumulation via sbp-1/fat-6-mediated signaling and increases activity
via sbp-1. These results can provide an important foundation for the
potential application of curcumin as a bioactive constituent in obesityprevention and/or treatment.
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